Clearmind Medicine (CMND) has recently entered into a non-binding agreement with Dr. Glitter Pty Ltd, a health technology firm renowned for its ActivCrystal technology. This innovative oral delivery system encapsulates active ingredients in crystals that are tasteless, odorless, crafted from natural components, and intended to be sprinkled onto meals. Both companies aim to collaborate on developing and commercializing Clearmind's MEAI-based alcohol substitute using Dr. Glitter Pty Ltd's ActivCrystal technology.
This partnership will focus on creating an MEAI-based alcohol alternative that seeks to naturally emulate the sensations associated with alcohol consumption, without the health risks or hangovers. In its ActivCrystal form, this MEAI-based substitute can be conveniently sprinkled onto any beverage or food of the user's choosing.
